Differential FDG accumulation associated with GLUT-1 expression in a patient with lymphoma
- PMID: 12932118
- DOI: 10.1007/BF02988530
Differential FDG accumulation associated with GLUT-1 expression in a patient with lymphoma
Abstract
We herein report a case of malignant lymphoma that showed differential FDG accumulation associated with the degree of glucose transporter 1 (GLUT-1) expression. For clinical staging purpose, FDG-PET was performed on a 47-year-old male who had been diagnosed to have malignant lymphoma, diffuse medium B-cell type. Although an X-ray CT showed multiple and bulky lymphadenopathy including bilateral submandibular, deep cervical, supraclavicular, axillar, hilar, mesenteric and paraaortic regions, FDG-PET showed a high accumulation only in the bilateral submandibular and deep cervical region. An immunohistochemical analysis demonstrated a high GLUT-1 expression in the right cervical lymph node, which showed a high FDG uptake. On the other hand, a bone marrow specimen with diffuse lymphoma cell involvement indicated showed no FDG accumulation and also revealed a negative GLUT-1 expression. This case suggests that the differential FDG accumulation shown by lesions is associated with the degree of GLUT-1 expression in patients with lymphoma.
Similar articles
-
A 18F-FDG-positive, 67Ga-negative, and transferrin receptor expression-negative patient with diffuse large B-cell lymphoma.Ann Nucl Med. 2007 Aug;21(6):375-8. doi: 10.1007/s12149-007-0037-8. Epub 2007 Aug 27. Ann Nucl Med. 2007. PMID: 17705020
-
Clinical significance of FDG single-photon emission computed tomography: Computed tomography in the diagnosis of head and neck cancers and study of its mechanism.Cancer Biother Radiopharm. 2008 Dec;23(6):701-14. doi: 10.1089/cbr.2008.0510. Cancer Biother Radiopharm. 2008. PMID: 19317609
-
18F-FDG uptake in squamous cell carcinoma of the cervix is correlated with glucose transporter 1 expression.J Nucl Med. 2004 Jan;45(1):22-9. J Nucl Med. 2004. PMID: 14734665 Clinical Trial.
-
Bilateral primary renal lymphoma in a pediatric patient: staging and response evaluation with ¹⁸F-FDG PET/CT.Rev Esp Med Nucl Imagen Mol. 2015 Jan-Feb;34(1):49-52. doi: 10.1016/j.remn.2014.05.004. Epub 2014 Jul 21. Rev Esp Med Nucl Imagen Mol. 2015. PMID: 25065972 Review.
-
Expression of glucose transporter-1, hypoxia-inducible factor-1α, phosphatidylinositol 3-kinase and protein kinase B (Akt) in relation to [(18)F]fluorodeoxyglucose uptake in nasopharyngeal diffuse large B-cell lymphoma: a case report and literature review.J Int Med Res. 2010;38(6):2160-8. doi: 10.1177/147323001003800632. J Int Med Res. 2010. PMID: 21227022 Review.
Cited by
-
Positron emission tomography in renal cell carcinoma: an imaging biomarker in development.Semin Nucl Med. 2012 Jul;42(4):221-30. doi: 10.1053/j.semnuclmed.2012.02.002. Semin Nucl Med. 2012. PMID: 22681671 Free PMC article. Review.
-
Dual time-point FDG PET/CT and FDG uptake and related enzymes in lymphadenopathies: preliminary results.Eur J Nucl Med Mol Imaging. 2016 Sep;43(10):1824-36. doi: 10.1007/s00259-016-3385-6. Epub 2016 Apr 22. Eur J Nucl Med Mol Imaging. 2016. PMID: 27102266
-
Correlation of GLUT-1 overexpression, tumor size, and depth of invasion with 18F-2-fluoro-2-deoxy-D-glucose uptake by positron emission tomography in colorectal cancer.Dig Dis Sci. 2006 Dec;51(12):2198-205. doi: 10.1007/s10620-006-9428-2. Epub 2006 Nov 2. Dig Dis Sci. 2006. PMID: 17080242
-
Glucose transporter 1 in health and disease.J Oral Maxillofac Pathol. 2019 Sep-Dec;23(3):443-449. doi: 10.4103/jomfp.JOMFP_22_18. J Oral Maxillofac Pathol. 2019. PMID: 31942129 Free PMC article. Review.
-
Correlation of pretreatment 18F-FDG uptake with clinicopathological factors and prognosis in patients with newly diagnosed diffuse large B-cell lymphoma.Nucl Med Commun. 2016 Jul;37(7):689-98. doi: 10.1097/MNM.0000000000000496. Nucl Med Commun. 2016. PMID: 27244584 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous